Canada markets open in 2 hours 49 minutes

MediPharm Labs Corp. (LABS.TO)

Toronto - Toronto Real Time Price. Currency in CAD
Add to watchlist
0.0900-0.0050 (-5.26%)
At close: 03:53PM EDT
Currency in CAD

Valuation Measures4

Market Cap (intraday) 36.12M
Enterprise Value 25.89M
Trailing P/E 187.00
Forward P/E N/A
PEG Ratio (5 yr expected) N/A
Price/Sales (ttm)1.00
Price/Book (mrq)0.65
Enterprise Value/Revenue 0.88
Enterprise Value/EBITDA -1.97

Trading Information

Stock Price History

Beta (5Y Monthly) N/A
52-Week Change 320.00%
S&P500 52-Week Change 329.57%
52 Week High 30.1000
52 Week Low 30.0550
50-Day Moving Average 30.0696
200-Day Moving Average 30.0697

Share Statistics

Avg Vol (3 month) 3231.93k
Avg Vol (10 day) 3568.12k
Shares Outstanding 5401.28M
Implied Shares Outstanding 6401.28M
Float 8279.61M
% Held by Insiders 12.47%
% Held by Institutions 10.73%
Shares Short (Mar 15, 2024) 4563.46k
Short Ratio (Mar 15, 2024) 43.79
Short % of Float (Mar 15, 2024) 4N/A
Short % of Shares Outstanding (Mar 15, 2024) 40.14%
Shares Short (prior month Feb 15, 2024) 4796.25k

Dividends & Splits

Forward Annual Dividend Rate 4N/A
Forward Annual Dividend Yield 4N/A
Trailing Annual Dividend Rate 30.00
Trailing Annual Dividend Yield 30.00%
5 Year Average Dividend Yield 4N/A
Payout Ratio 40.00%
Dividend Date 3N/A
Ex-Dividend Date 4N/A
Last Split Factor 2N/A
Last Split Date 3N/A

Financial Highlights

Fiscal Year

Fiscal Year Ends Dec 31, 2023
Most Recent Quarter (mrq)Dec 31, 2023

Profitability

Profit Margin -39.57%
Operating Margin (ttm)-25.88%

Management Effectiveness

Return on Assets (ttm)-17.63%
Return on Equity (ttm)-24.00%

Income Statement

Revenue (ttm)33.06M
Revenue Per Share (ttm)0.10
Quarterly Revenue Growth (yoy)62.60%
Gross Profit (ttm)N/A
EBITDA -15.74M
Net Income Avi to Common (ttm)-13.08M
Diluted EPS (ttm)-0.0500
Quarterly Earnings Growth (yoy)N/A

Balance Sheet

Total Cash (mrq)17.98M
Total Cash Per Share (mrq)0.06
Total Debt (mrq)2.29M
Total Debt/Equity (mrq)4.33%
Current Ratio (mrq)3.37
Book Value Per Share (mrq)0.18

Cash Flow Statement

Operating Cash Flow (ttm)-12.34M
Levered Free Cash Flow (ttm)-3.99M